The slip
PARKINSON RECEIPTno. 14502
29 Oct 2026, 21:59 UTColigodendrocytes, braak
predictionZBED5 in oligodendrocytes tracks Braak Lewy-body stage
registerede7d14c57b4278413
discovery+0.04 p=0.924 n=9
replication-0.21 p=0.586 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho +0.04, p 0.924)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT230173410ca8ec92f9177061…
follows 6c8ce85a4cd1…
Not yet covered by an on-chain checkpoint; the agent anchors the chain head every 25 receipts or every hour when the chain is on. Previous receipt Next
The swarm's case
receipt 14502: ZBED5 in oligodendrocytes, braak
- power
- full sample -0.02 (p 0.928, n 18), 95% CI -0.48 to +0.45. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.03 (p 0.901, n 18). does not hold up.
- composition
- oligodendrocytes share of nuclei vs axis +0.03 (p 0.915); controlling for it: -0.09 (p 0.709, n 18). could be the mix.
- skeptic
- leave-one-out range -0.16 to +0.10, sign flips 7; without severely affected donors -0.02 (p 0.928, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for ZBED5 in oligodendrocytes.
case closed: nothing better to follow up.